OPT - Opthea Limited - Strawman: ASX share price, valuation, research and discussion

Reports (1) My Report Forum Investors

Top member reports

Consensus

No meetings

Consensus community valuation

The consensus valuation is for members only and has been removed from this chart. Click for membership options.

Become a member

Contributing Members

Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.

Become a member

Valuation of $5.00

stale

Jimmy

Added 4 years ago

High Risk / High Reward: OPT is a biotechnology company focused on development of new drugs for the treatment of eye diseases. Targeting a huge market OPT has so far done everything right and in my opinion will experience a significant re-rating of it's share price should the trials prove as successful as most anticipate.

Opthea Limited

Opthea Limited

Set Price Alert for OPT

Consensus community valuation

Contributing Members

Place trade